News/ News/ R&D Chinese biotech Sironax raises $200m for RIPK1 pipeline Phil Taylor China, Eli Lilly, financing, Genfleet Therapeutics, GlaxoSmithKline, Immunology and inflammation, Rigel Pharmaceuticals, RIPK1, Sanofi, Sironax 0 Comment Beijing biotech Sironax has closed a whopping $200 million second-round financing that shows investors still have a desire Share X Chinese biotech Sironax raises $200m for RIPK1 pipeline https://pharmaphorum.com/news/chinese-biotech-sironax-raises-200m-for-ripk1-pipeline/